Late release of circulating endothelial cells and endothelial progenitor cells after chemotherapy predicts response and survival in cancer patients.
about
Dinosaurs and ancient civilizations: reflections on the treatment of cancerAntiangiogenesis therapy for breast cancer: an update and perspectives from clinical trialsAn Integrated Platform for Isolation, Processing, and Mass Spectrometry-based Proteomic Profiling of Rare Cells in Whole Blood.Myelosuppression of thrombocytes and monocytes is associated with a lack of synergy between chemotherapy and anti-VEGF treatment.Efficient in vivo selection of a novel tumor-associated peptide from a phage display library.Characterization of vascular endothelial progenitor cells from chicken bone marrowDevelopment of a new positron emission tomography tracer for targeting tumor angiogenesis: synthesis, small animal imaging, and radiation dosimetry.The interconnectedness of cancer cell signaling.Elevated MARCKS phosphorylation contributes to unresponsiveness of breast cancer to paclitaxel treatmentPhase I and pharmacological study of pazopanib in combination with oral topotecan in patients with advanced solid tumours.Notch1 regulates angio-supportive bone marrow-derived cells in mice: relevance to chemoresistance.Clinical value of circulating endothelial cells and of soluble CD146 levels in patients undergoing surgery for non-small cell lung cancer.New anti-angiogenic strategies in pediatric solid malignancies: agents and biomarkers of a near future.Strategies for improving the clinical benefit of antiangiogenic drug based therapies for breast cancer.Treatment-induced host-mediated mechanisms reducing the efficacy of antitumor therapies.Tumor vascularity in prostate cancer: an update on circulating endothelial cells and platelets as noninvasive biomarkers.Prior exposure to chemotherapy: a marker of sensitivity and selection for antiangiogenic therapy in breast cancer?Circulating endothelial progenitor cell: a promising biomarker in clinical oncology.The novel chemokine receptor CXCR7 regulates trans-endothelial migration of cancer cells.Neoadjuvant chemotherapy induces breast cancer metastasis through a TMEM-mediated mechanism.Overcoming intratumor heterogeneity of polygenic cancer drug resistance with improved biomarker integrationChanges in circulating endothelial progenitor cells predict responses of multiple myeloma patients to treatment with bortezomib and dexamethasone.Pilot study to relate clinical outcome in pancreatic carcinoma and angiogenic plasma factors/circulating mature/progenitor endothelial cells: Preliminary results.Predictive and prognostic value of circulating endothelial cells in non-small cell lung cancer patients treated with standard chemotherapy.Increase in circulating endothelial progenitor cells predicts response in patients with advanced non-small-cell lung cancer.Chemotherapy-induced metastasis: mechanisms and translational opportunities.Serum anti-endothelial cell antibodies in patients with age-related macular degeneration treated with intravitreal bevacizumab.Phase II study of bevacizumab, cisplatin, and docetaxel plus maintenance bevacizumab as first-line treatment for patients with advanced non-squamous non-small-cell lung cancer combined with exploratory analysis of circulating endothelial cells: ThorCirculating perivascular progenitors: a target of PDGFR inhibition.Competition and niche construction in a model of cancer metastasis.
P2860
Q24628746-C842FF98-8A88-46B2-950A-FA34D4EE4367Q26822432-22AEC6A9-62D2-49FD-BD6E-450BEB1C55BAQ30382499-D01F924C-1843-4A3F-BA43-29B0DA1154F2Q33395123-7AAE9A7B-CABD-46E0-95F4-D8CA265B5033Q33800886-AB3E020C-B77E-449D-8CF9-FD0CFA7371DBQ34268512-47286CC5-9E93-4854-9D78-6711BC699293Q34724473-941CC0CC-2985-4857-9E18-3EDC83AAB6BBQ35669733-A92A9983-490D-41AE-965A-71CEF9A55F1AQ36020972-1CD8740E-CEB0-46AE-AE0A-5D8BAE30F2E1Q36027042-430DF7CC-17EA-405C-A90B-7037B533BC4EQ36983730-DC2913E2-DAFD-454C-9189-9F43E7C4975EQ37632126-528892E4-E28B-428D-86B6-F181C775D2FAQ37752435-8D63A173-7293-422B-8B94-0E7D4CB20D13Q38046514-83CA9343-E145-4690-A824-13DA40F9DFE2Q38092582-98362AF8-8AD8-46E4-9A28-4FF604958F3AQ38165245-A574888D-C92D-4EA6-AD08-710ABA738120Q38168926-03E20234-670E-4D09-BB06-95FECB0C88C4Q38271842-11D1D2E4-EF9C-451A-9C7B-FEA0C6AAF1BFQ39524797-697E1429-A1E0-4DEA-81F7-6D9DE6E3BF08Q40134207-3EC4B786-3AB0-4B2A-B656-039C873C49BAQ41879186-65615B0E-CC84-40CE-86E1-E1481F094B41Q42639683-DC7CC294-03C5-4A85-BB28-34AE5D57EBABQ42857353-DFC0F837-209E-4E1C-8AE8-7994AA0FDD2DQ44265169-A9EF7BCF-9CF1-4EA9-9BE6-EAF002FE98CEQ44864734-D9853826-63F3-4214-8B16-9B59DEEF283AQ50146851-FC5AD4D0-E3F4-4213-9525-1F9E83CBC5B6Q51689746-5DCC4B8B-8433-4781-B97C-60C36FDE537FQ52676775-BBBFF3F4-364E-4A76-97F7-666FD284A74EQ54628938-A234968E-2C0D-44D3-B2B3-7F89C3A9590EQ55333033-454B5A50-2674-4CB4-B799-0BAA9AFE161D
P2860
Late release of circulating endothelial cells and endothelial progenitor cells after chemotherapy predicts response and survival in cancer patients.
description
2010 nî lūn-bûn
@nan
2010 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Late release of circulating en ...... d survival in cancer patients.
@ast
Late release of circulating en ...... d survival in cancer patients.
@en
Late release of circulating en ...... d survival in cancer patients.
@nl
type
label
Late release of circulating en ...... d survival in cancer patients.
@ast
Late release of circulating en ...... d survival in cancer patients.
@en
Late release of circulating en ...... d survival in cancer patients.
@nl
prefLabel
Late release of circulating en ...... d survival in cancer patients.
@ast
Late release of circulating en ...... d survival in cancer patients.
@en
Late release of circulating en ...... d survival in cancer patients.
@nl
P2093
P2860
P356
P1433
P1476
Late release of circulating en ...... d survival in cancer patients.
@en
P2093
Arnold Baars
Els O Witteveen
Emile E Voest
Jeanine M Roodhart
Joost S Vermaat
Marlies H Langenberg
Martijn P Lolkema
P2860
P356
10.1593/NEO.91460
P577
2010-01-01T00:00:00Z